Drug that could tackle Omicron variant approved by UK regulators

The MHRA has approved a new drug for treating people at risk of severe Covid-19 (Andy Buchanan/PA)

A drug treatment which, the makers say, works against the new Omicron variant of Covid-19, has been approved by UK regulators.

Xevudy (sotrovimab), made by pharmaceutical giant GlaxoSmithKline (GSK), has been found to cut hospital admission and death by 79% in those at risk.